Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.96 +0.01 (+1.45%)
As of: Sep 30, 2026 · 11:43 AM EDT

Lineage Cell Therapeutics (LCTX) Total Non-Current Liabilities (2010 - 2026)

Updated

Lineage Cell Therapeutics (LCTX) recorded Total Non-Current Liabilities of $20.61 million in Q2 2026, down 17.2% from $24.89 million a year earlier and down 9.2% from the prior quarter.

Analysis

Lineage Cell Therapeutics (LCTX) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Lineage Cell Therapeutics reported Total Non-Current Liabilities of $24.13 million, down 19.7% from FY2024.

  • Annual Total Non-Current Liabilities has declined for four straight years, with a four-year compound annual growth rate of -26.7% (FY2021 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $30.05 million in FY2024 (-23.0%), $39 million in FY2023 (-24.6%), $51.73 million in FY2022 (-38.1%) and $83.62 million in FY2021.
  • The Q2 2026 figure is the lowest quarterly Total Non-Current Liabilities since Q4 2018.
  • On a year-over-year basis, Total Non-Current Liabilities has declined for three consecutive quarters, with an average decline of 19.7% over the last four quarters.
  • Per Business Quant, the preceding three quarters came in at $22.7 million (Q1 2026), $24.13 million (Q4 2025) and $22.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Lineage Cell Therapeutics 245.32 Mn 43.73 Mn - 20.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.61 Mn
Mar 31, 2026 22.70 Mn
Dec 31, 2025 24.13 Mn
Sep 30, 2025 22.43 Mn
Jun 30, 2025 24.89 Mn
Mar 31, 2025 28.04 Mn
Dec 31, 2024 30.05 Mn
Dec 31, 2023 39.00 Mn
Dec 31, 2022 51.73 Mn
Dec 31, 2021 83.62 Mn
Dec 31, 2018 9.17 Mn
Sep 30, 2018 6.28 Mn
Jun 30, 2018 7.31 Mn
Mar 31, 2018 7.83 Mn
Dec 31, 2017 8.87 Mn
Sep 30, 2017 12.33 Mn
Jun 30, 2017 15.09 Mn
Mar 31, 2017 15.45 Mn
Dec 31, 2016 12.01 Mn
Sep 30, 2016 11.29 Mn
API Access

Lineage Cell Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=LCTX&period=max&api_key=YOUR_API_KEY